Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

300642 Tellgen Corporation

19.900
+0.420+2.16%
Market Close 09/29 15:00 CCT
High
20.230
Open
19.670
Turnover
36.13M
Low
19.450
Pre Close
19.480
Volume
18.08K
Market Cap
3.26B
P/E(TTM)
25.19
52wk High
42.430
Shares
163.83M
P/E(Static)
20.24
52wk Low
18.600
Float Cap
2.76B
Bid/Ask %
2.28%
Historical High
49.778
Shs Float
138.77M
Volume Ratio
1.87
Historical Low
16.528
Dividend TTM
0.25
Div Yield TTM
--
P/B
2.36
Dividend LFY
1.26%
Div Yield LFY
--
Turnover Ratio
1.30%
Amplitude
4.00%
Avg Price
19.978
Lot Size
100
Float Cap
2.76B
Bid/Ask %
2.28%
Historical High
49.778
Shs Float
138.77M
Volume Ratio
1.87
Historical Low
16.528
Dividend TTM
0.25
Limit Up
23.380
P/B
2.36
Dividend LFY
1.26%
Limit Down
15.580
Turnover Ratio
1.30%
Amplitude
4.00%
Avg Price
19.978
Lot Size
100
Ask
7.64Klots
Bid
10.19Klots
Price Forecast

No Data

News

Comment

Company Overview More
Founded in 2003, the company is located in Shanghai Zhangjiang High-tech Park, which is known as "China Pharmaceutical Valley". It was successfully listed on April 21, 2017. The company is mainly engaged in the R & D, production and sales of independent brand in vitro diagnostic products, which are mainly related to tumor-related testing, autoimmune testing, etc., and the company's main business has not changed during the reporting period. According to the detection principle, the company's products can be divided into three categories: immune, molecular and biochemical diagnosis products. The company comprehensively uses high-throughput fluorescence technology, chemiluminescence immunoassay technology, multi-color fluorescence PCR technology and other technology platforms to develop in vitro diagnostic reagents, forming a rich product line of "clinical detection of the whole course of tumor, supplemented by detection products in other fields", covering all aspects of the whole course of tumor screening-auxiliary diagnosis-personalized medication-prognosis and curative effect monitoring. Widely used in the field of clinical diagnosis.
CEO: --
Market: --
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...